Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life
Clinical Trials Friday, May 17th, 2013STROKEAHA: May 9, 2013
Background and Purpose—High blood pressure is common in the acute phase of stroke and is associated with poor outcome. We examined whether blood pressure–lowering treatment with candesartan in the acute phase affects long-term cognitive function and quality of life.
Methods—Scandinavian Candesartan Acute Stroke Trial was a randomized-controlled and placebo-controlled trial of candesartan in 2029 patients with acute stroke and raised blood pressure. Read more
